NLM Logo

Episodic Ataxia, Type 2 MeSH Supplementary Concept Data 2024


MeSH Supplementary
Episodic Ataxia, Type 2
Unique ID
C535506
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C535506
Entry Term(s)
Acetazolamide-Responsive Hereditary Paroxysmal Cerebellar Ataxia
Acetazolamide-responsive episodic ataxia syndrome
Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia
Ataxia, Episodic, With Nystagmus
Ataxia, Familial Paroxysmal
Ataxia, familial, paroxysmal
Cerebellar ataxia, paroxysmal, Acetazolamide-responsive
Cerebellopathy, hereditary paroxysmal
Episodic Ataxia, Nystagmus-Associated
Episodic ataxia type 2
Episodic ataxia with nystagmus
Nystagmus-associated episodic ataxia
Registry Number
0
Heading Mapped to
*Ataxia
*Nystagmus, Pathologic
Frequency
42
Note
The most common form of episodic ataxia, a genetically heterogeneous condition characterized by episodes of incoordiantion and imbalance similar to progressive ataxia. Episodic ataxia 2 exhibits autosomal dominant inheritance and is further characterized by onset in childhood or adolescence and the occurence of nystagmus, TINNITUS; MIGRAINE HEADACHE, and other neurologic symptoms. Episodes are often triggered by sudden movements, fatigue, stress, stimulant or alcohol use and may be treated by ACETAZOLAMIDE. Mutations in the CACNA1A gene have been identified. OMIM: 108500
Date of Entry
2010/08/25
Revision Date
2015/08/18
Episodic Ataxia, Type 2 Preferred
page delivered in 0.005s